Nijmegen breakage syndrome in 13% of age-matched Czech children with primary microcephaly
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
15033202
DOI
10.1016/j.pediatrneurol.2003.07.003
PII: S0887899403004399
Knihovny.cz E-resources
- MeSH
- Chromosome Aberrations * MeSH
- Chromosome Deletion MeSH
- Chromosomal Instability genetics MeSH
- Child MeSH
- Adult MeSH
- Gene Frequency genetics MeSH
- Genetic Testing MeSH
- Genes, Recessive genetics MeSH
- Homozygote MeSH
- Nuclear Proteins genetics MeSH
- Cohort Studies MeSH
- Infant MeSH
- Humans MeSH
- Intellectual Disability diagnosis epidemiology genetics MeSH
- Microcephaly diagnosis epidemiology genetics MeSH
- Adolescent MeSH
- Genetics, Population MeSH
- Child, Preschool MeSH
- Cell Cycle Proteins genetics MeSH
- Cross-Sectional Studies MeSH
- Fetal Growth Retardation diagnosis epidemiology genetics MeSH
- Immunologic Deficiency Syndromes diagnosis epidemiology genetics MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic epidemiology MeSH
- Names of Substances
- Nuclear Proteins MeSH
- NBN protein, human MeSH Browser
- Cell Cycle Proteins MeSH
The Nijmegen breakage syndrome is a rare autosomal recessive chromosomal instability disorder characterized by early growth retardation, congenital microcephaly, immunodeficiency, borderline mental development, and a high tendency to lymphoreticular malignancies. Most Nijmegen breakage syndrome patients are of Slavonic origin, and all of them known so far carry a founder homozygous 5 nucleotide deletion in the NBS1 gene. Microcephaly was present in 100% of Nijmegen breakage syndrome patients in a recent large international cooperative study. The frequency of Nijmegen breakage syndrome among children with primary microcephaly was not known. Early correct diagnosis of the syndrome is crucial for appropriate preventive care and therapy. We tested 67 Czech patients of different ages with simple microcephaly for the presence of the most common mutation in the NBS1 gene. Three new Nijmegen breakage syndrome cases were detected in this cohort, representing 4.5% of the cohort. All these newly diagnosed Nijmegen breakage syndrome patients were younger than 10 months at the time of diagnosis. They were all born within a 2.5-year period. Twenty-three of the 67 children in the cohort were born within this 2.5-year period, representing a 13% incidence of Nijmegen breakage syndrome. Frequency of Nijmegen breakage syndrome heterozygotes among infants in the Czech Republic is 1: 130-158 and the birth rate is 90,000 per year, therefore in the time span of 2.5 years, three new Nijmegen breakage syndrome homozygotes are expected to be born. Therefore we assume that by DNA testing of Czech primary microcephalic children it is possible to detect all Nijmegen breakage syndrome patients to be expected. The age at correct diagnosis was lowered from 7.1 years at the time before DNA testing, to well under 1 year of age. All new Nijmegen breakage syndrome patients could receive appropriate preventive care, which should significantly improve their life expectancy and prognosis.
References provided by Crossref.org
The NBN founder mutation-Evidence for a country specific difference in age at cancer manifestation
The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability